Chimeric antigen receptor (CAR-T) therapies have shown promise in targeting difficult-to-treat cancers; however, predicting the efficacy, durability, and response of these therapies remains a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback